EDGAR Filing Documents for 0001193125-18-361016

Form SC 13G - Statement of acquisition of beneficial ownership by individuals:

SEC Accession No. 0001193125-18-361016

Filing Date

2018-12-28

Accepted

2018-12-28 16:42:34

Documents

Group Members

CRG ISSUER 2017-1CRG PARTNERS III (CAYMAN) LEV AIV I L.P.CRG PARTNERS III (CAYMAN) UNLEV AIV I L.P.CRG PARTNERS III L.P.CRG PARTNERS III PARALLEL FUND A L.P.CRG PARTNERS III PARALLEL FUND B (CAYMAN) L.P.NATHAN D. HUKILL

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G	d679740dsc13g.htm	SC 13G	136388
2	EX-99.1	d679740dex991.htm	EX-99.1	7327
	Complete submission text file	0001193125-18-361016.txt		145576

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Subject) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: SC 13G | Act: 34 | File No.: 005-89153 | Film No.: 181257816
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002

Business Address 1000 MAIN STREET, SUITE 2500 HOUSTON TX 77002 713-209-7350

Capital Royalty L.P. (Filed by) CIK: 0001702352 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G